Back to Search Start Over

Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells

Authors :
Jessica Shama
Jacques Pouysségur
Raquel Garcia-Medina
Emmanuel Vial
Institut de signalisation, biologie du développement et cancer (ISBDC)
Centre National de la Recherche Scientifique (CNRS)-Université Nice Sophia Antipolis (... - 2019) (UNS)
COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)
Source :
Biochemical and Biophysical Research Communications, Biochemical and Biophysical Research Communications, Elsevier, 2008, 372 (4), pp.845-9. ⟨10.1016/j.bbrc.2008.05.135⟩
Publication Year :
2008
Publisher :
Elsevier BV, 2008.

Abstract

Mammalian cells express two closely related MEK isoforms, MEK1 and MEK2, upstream of the ERK1/ERK2 MAPK module. Although genetic studies have suggested that MEK1 and MEK2 do not have overlapping functions in vivo, little is known about their specific contribution to the activation of ERKs and to tumor cell proliferation. We used Tet-inducible shRNA to investigate the independent role of MEK1 and MEK2 for the oncogenic and the serum-induced activation of ERK1 and ERK2 in LS174T colon carcinoma cells. We show that MEK1 is the main activator of both ERK1 and ERK2. MEK2 removal has no impact by itself but it can cooperate with MEK1 ablation for the inhibition of ERK1/2 activity. In addition, we show that MEK1 is the critical isoform regulating tumor cell proliferation in vitro and in vivo.

Details

ISSN :
0006291X and 10902104
Volume :
372
Database :
OpenAIRE
Journal :
Biochemical and Biophysical Research Communications
Accession number :
edsair.doi.dedup.....8bcc4aef1f71662779bede4d5bb9e40a
Full Text :
https://doi.org/10.1016/j.bbrc.2008.05.135